Menu
Not yet recruiting NCT07618754

Shame, Resilience and Well-being After Intimate Partner Violence: an Intervention Study With Replicated Single-Subject Design.

No phase Interventional Intimate Partner Violence Resilience, Psychological

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Resilience enhancing intervention, individual format, Resilience enhancing intervention, group format.
Who it may be relevant to
Registry conditions: Intimate Partner Violence, Resilience, Psychological. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Sweden
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The EMBER protocol is a health care method that is designed to increase resilience, in order to improve well-being and overall health in women who have experienced violence by a partner. This study explores whether the EMBER intervention works in this way. Eight participants will take part in the EMBER program and complete questionnaires every week during the intervention. The researchers will compare the timeline for the intervention to how resilience levels change. They will also check whether changes in resilience are linked to changes in health and well-being.

Detailed description

Intimate partner violence (IPV) is a global problem with complex consequences in society as well as for the victim/survivor. The EMBER-protocol was developed at National Center for Knowledge on Men´s violence against Women, Uppsala University, Sweden. The purpose of the protocol is to provide women who have been subjected to IPV with support and tools for empowerment and improving resilience, thereby improving health and well-being. In this study with replicated single-case design, 8 patients will complete questionnaires bi-weekly while taking part of the intervention, starting from their very first contact with the clinic. The questionnaires are completed using a mobile application. Data will be processed using a combination of visual and statistical analysis, in order to examine how interventions intended to improve resilience, changes in resilience measures and changes in well-being and health relate to each other temporally.

Interventions

  • Other Resilience enhancing intervention, individual format
    A 4-step, Resilience-focused intervention based on the Resilience Portfolio Model, administered in individual format.
  • Other Resilience enhancing intervention, group format
    A 4-step, Resilience-focused intervention based on the Resilience Portfolio Model, administered in group format.

Primary outcome measures

  • Resilience - Psychological Endurance [Time frame: Bi-weekly from enrollment 2-6 weeks prior to start of intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.]
  • Resilience - Subjective Social Support [Time frame: Bi-weekly from enrollment 2-6 weeks prior to start of intervention to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.]
  • Resilience - Meaning Making [Time frame: Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.]
Secondary outcome measures (3)
  • Health [Time frame: Bi-weekly from enrollment 2-6 weeks prior to the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.]
  • Shame [Time frame: Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 at weeks post-intervention.]
  • Well-Being [Time frame: Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up at 6 weeks post-intervention.]

Eligibility criteria

Inclusion criteria

  • subjected to IPV within 2 years prior to enrollment
  • capable of completing questionnaires using a mobile phone
  • intention to complete intervention
  • identifies as female

Exclusion criteria

  • ongoing severe IPV
  • ongoing severe substance use
  • psychosis
  • moderate to severe suicidality
  • ongoing psychological intervention in other facility

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Sweden · 1 center
  • Uppsala University Hospital — Uppsala

Identifiers

NCT: NCT07618754 · EMBER-4

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗